Related Experiment Video

Updated: May 20, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

SLC45A3-ELK4 chimera in prostate cancer: spotlight on cis-splicing

Chandan Kumar-Sinha1, Shanker Kalyana-Sundaram, Arul M Chinnaiyan

  • 1Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.

Cancer Discovery
|July 13, 2012
PubMed

Insights

The prostate cancer RNA chimera SLC45A3-ELK4 arises from cis-splicing, not DNA changes. This chimera promotes prostate cancer cell growth, unlike normal ELK4.

Area of Science:

  • Molecular biology
  • Cancer research
  • Genetics

Background:

  • Prostate cancer is a significant health concern.
  • RNA chimeras can play a role in cancer development.
  • The SLC45A3-ELK4 chimera has been observed in prostate cancer.

Purpose of the Study:

  • To elucidate the formation mechanism of the SLC45A3-ELK4 prostate cancer RNA chimera.
  • To investigate the regulatory factors involved in its expression.
  • To determine the functional impact of the chimera on prostate cancer cell proliferation.

Main Methods:

  • Detailed experimental analysis.
  • Gene expression studies.
  • Cell proliferation assays.

Main Results:

  • The SLC45A3-ELK4 chimera is formed via cis-splicing between adjacent genes.
  • Its expression is induced by androgen treatment.
  • Androgen signaling likely overcomes CCCTC insulator-mediated repression.
  • The chimeric transcript enhances prostate cancer cell proliferation.

Conclusions:

  • The SLC45A3-ELK4 chimera is generated through a cis-splicing mechanism.
  • Androgen signaling is a key regulator of its expression.
  • This chimera contributes to prostate cancer progression by promoting cell proliferation.

More Related Videos

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...